Jacqueline S. Gardner
University of Washington
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Jacqueline S. Gardner.
Cancer | 2004
Denise M. Boudreau; Jacqueline S. Gardner; Kathleen E. Malone; Susan R. Heckbert; David K. Blough; Janet R. Daling
Statin use has increased dramatically in the U.S. in the past decade. Animal and mechanistic studies suggested that statins may have an inhibitory effect on cancer proliferation, including breast carcinoma. However, statins have been found to be carcinogenic in rodents and one clinical trial found an excess of breast carcinoma cases in the treatment group.
Pharmacotherapy | 2000
Jacqueline S. Gardner; David K. Blough; Carol R. Drinkard; Deborah Shatin; Gail D. Anderson; David J. Graham; Raymond J. Alderfer
Study Objective. To investigate the occurrence of tramadol‐associated seizures.
American Journal of Public Health | 2001
Kristin D. Marciante; Jacqueline S. Gardner; David L. Veenstra; Sean D. Sullivan
OBJECTIVES This study investigated the effect on the risk and cost of unintended pregnancies of emergency contraceptive pills obtained directly from a pharmacist. METHODS We used a decision model to compare outcomes for private and public payers following unprotected intercourse from. RESULTS Obtaining emergency contraceptive pills from a pharmacy, compared with obtaining them from a physician or clinic, resulted in a
BMC Public Health | 2011
Joseph B. Babigumira; Andy Stergachis; David L. Veenstra; Jacqueline S. Gardner; Joseph Ngonzi; Peter Mukasa-Kivunike; Louis P. Garrison
158 (95% confidence interval (CI) =
Journal of The American Pharmaceutical Association | 1997
Jacqueline S. Gardner
76,
PLOS ONE | 2012
Joseph B. Babigumira; Andy Stergachis; David L. Veenstra; Jacqueline S. Gardner; Joseph Ngonzi; Peter Mukasa-Kivunike; Louis P. Garrison
269) reduction in costs for private payers and a
Disease Management & Health Outcomes | 2002
Judith A. Soon; Marc Levine; Mary H. H. Ensom; Jacqueline S. Gardner; Hilary M. Edmondson; David W. Fielding
48 (95% CI =
Pharmacoepidemiology and Drug Safety | 1996
Jacqueline S. Gardner; Cheryl A. Szpunar; martin J. O'Connell; David P. Facklam; Joseph P. Mariano; E. Keith Borden; Frank B. Leinweber
16,
Clinical Pharmacology & Therapeutics | 2011
Jt Cross; David L. Veenstra; Jacqueline S. Gardner; Louis P. Garrison
93) reduction for public payers. CONCLUSIONS Our findings suggest that under varied assumptions, obtaining emergency contraceptive pills directly from a pharmacist reduces the number of unintended pregnancies and is cost saving.
Pharmacoepidemiology and Drug Safety | 1996
Jacqueline S. Gardner; Cheryl A. Szpunar; Martin J. O’Connell; David P. Facklam; Joseph P. Mariano; E. Keith Borden; Frank B. Leinweber
BackgroundThe demand for induced abortions in Uganda is high despite legal and moral proscriptions. Abortion seekers usually go to illegal, hidden clinics where procedures are performed in unhygienic environments by under-trained practitioners. These abortions, which are usually unsafe, lead to a high rate of severe complications and use of substantial, scarce healthcare resources. This study was performed to estimate the costs associated with induced abortions in Uganda.MethodsA decision tree was developed to represent the consequences of induced abortion and estimate the costs of an average case. Data were obtained from a primary chart abstraction study, an on-going prospective study, and the published literature. Societal costs, direct medical costs, direct non-medical costs, indirect (productivity) costs, costs to patients, and costs to the government were estimated. Monte Carlo simulation was used to account for uncertainty.ResultsThe average societal cost per induced abortion (95% credibility range) was